Professional Documents
Culture Documents
IP2 Group 11
IP2 Group 11
Presented by –
Shriyesh sawant (104)
Pranali Shete (105) Under guidance of –
Saurabh Shete (106) Dr. Sandip Honmane
Abhay Shinde (107)
Content -
Introduction to OOS
Procedure of OOS
OOS investigations
Scope of OOS
Change control
Procedure of change control
Change control in pharmaceutical industries
Introduction -
Out of specification means the test result that falls outside the
specifications or acceptance criteria which has been specified in
official compendia monographs or finished product specifications in
registration dossiers.
OOS is the comparison of one result versus a predetermined
specification criterion while OOT (out of trend) is the comparison of
many historical data versus time.
OOS is observed in the analysis of :
Stability study
Finished product
In process
Raw materials
Packaging materials
USFDA guideline for industry investigating OOS testing results for
pharmaceutical production has two phases:
PhaseI: Laboratory investigation: It includes an initial assessment of
accuracy of laboratory data.
PhaseII: Full-scale OOS investigation: It consists of production
process review and or additional laboratory work.
Procedure of OOS -
1) Proposing a Change
2) Evaluating effect of change on product quality
3) Approval of a change
4) Implementing a change
5) Storage of completed change control
6) Trending change control metrics
7) Emergency change control
Procedure for change control -
Change control in pharmaceutical
industries -